# Inflammatory Response Secondary Using Intravenous Anesthesia Versus Inhalation Anesthesia With Halogenated Agents

> **NCT02168751** · PHASE4 · COMPLETED · sponsor: **Hospital General Universitario Gregorio Marañon** · enrollment: 180 (actual)

## Conditions studied

- Pulmonary Resection

## Interventions

- **DRUG:** propofol
- **DRUG:** Sevoflurane

## Key facts

- **NCT ID:** NCT02168751
- **Lead sponsor:** Hospital General Universitario Gregorio Marañon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2016-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168751, "Inflammatory Response Secondary Using Intravenous Anesthesia Versus Inhalation Anesthesia With Halogenated Agents". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02168751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*